Trial Profile
Evaluation of efficacy and safety of Dabigatran in patients with catheter ablation for atrial fibrillation.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions; Therapeutic Use
- 27 Jul 2013 New trial record